NCT01273935

Dose-Dependent Effect of Early Antiplatelet Therapy in Acute Ischemic Stroke

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 400 (actual)
• Sponsor: Ruhr University of Bochum · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to evaluate the low-response prevalence of early antiplatelet therapy and to test the influence of different aspirin dosages in patients with acute ischemic strokes (AIS).

Detailed description

Antiplatelet agents are important therapeutic options in treating patients with acute ischemic strokes to prevent recurrent ischemic events or death. The aim of this study was to evaluate the low-response prevalence of early antiplatelet therapy and the influence of different aspirin dosages in patients with acute ischemic strokes (AIS).

Conditions

• Test the Efficacy of Antiplatelet Regimes in Acute Stroke

Timeline

• Start date: 2010-01-01
• Completion: 2010-12-01
• First posted: 2011-01-11
• Last updated: 2011-01-11

Locations

1 site across 1 country: Germany